Successful treatment with vincristine in PHACES syndrome

Clinical and Translational Oncology

Volumn 9, Issue 4, 2007, Pages 262-263

  Herrero Hernandez A ^a   Escobosa Sanchez O ^a   Acha Garcia T ^a  

^a HOSPITAL MATERNO INFANTIL   (Spain)

Author keywords

Corticosteroid; Haemangioma of infancy; PHACES syndrome; Vincristine

Indexed keywords

PREDNISONE; RANITIDINE; VINCRISTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GLUCOCORTICOID;

ARTERY MALFORMATION; ARTICLE; BONE DEFECT; BRAIN MALFORMATION; CASE REPORT; CLINICAL FEATURE; CONSTIPATION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG WITHDRAWAL; EYE MALFORMATION; FACE MALFORMATION; FEMALE; HEART DISEASE; HEMANGIOMA; HOSPITAL ADMISSION; HUMAN; INFANT; INFANT DISEASE; INSOMNIA; IRIS COLOBOMA; IRRITABILITY; MOON FACE; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT REFERRAL; PERSONALITY DISORDER; PHACES SYNDROME; POSTERIOR FOSSA; SIDE EFFECT; SKIN; SLEEP APNEA SYNDROME; STERNUM; STOMACH IRRITATION; TREATMENT OUTCOME; AGE; CHEMICALLY INDUCED DISORDER; FACE TUMOR; FOLLOW UP; MULTIPLE MALFORMATION SYNDROME; SYNDROME; TIME;

ABNORMALITIES, MULTIPLE; AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CONSTIPATION; EYE ABNORMALITIES; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; INFANT; PREDNISONE; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 34447101962     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0050-3     Document Type: Article

References (14)

1. Metry D (2004) Update on hemangiomas of infancy. Curr Opin Pediatr 16:373-377
2. Frieden I, Haggstrom A, Drolet B et al (2005) Infantile hemangiomas: current knowledge, future directions. Proceeding of a research workshop on infantile hemangiomas. Pediatr Dermatol 22:383-406
3. Boon L, MacDonald D, Mulliken J (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104:1616-1623
4. Enjolras O, Brevière GM, Roger G et al (2004) Traitement par vincristine des hemangiomes graves du nourrisson. Vincristine treatment for function and life-threatening infantile hemangioma. Arch Pediatr 11:99-107
5. Achauer B, Chang C, Vander Kam V (1997) Management of hemangioma of infancy: Review of 245 patients. Plast Reconstr Surg 99:1301-1308
6. George ME, Sharma V, Jacobson J et al (2004) Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 140:963-969
7. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol 137:1208-1213
8. Lloret P (2004) Medical treatment of haemangiomas. An Sist Sanit Navar 27:81-92
9. Mulliken J, Enjolras O (2004) Congenital hemangiomas and infantile hemangioma: Missing links. J Am Acad Dermatol 50:875-882
10. Chang E, Boyd A, Nelson C et al (1997) Successful treatment of infantile hemangiomas with interferon alpha-2b. J Ped Hema Oncol 19:237-244
11. Enjolras O, Breviene GM, Roger G et al (2004) Vincristine treatment for function and lifethreatening infantile hemangioma. Arch Pediatr 11:99-107
12. López-Gutiérrez JC (2004) Anomalías vasculares congénitas. An Pediatr Contin 2:365-369
13. Enjolras O (1998) Neurotoxicity of interferon alfa in children treated for hemangiomas. J Am Acad Dermatol 39:1037-1038
14. Pascual-Castroviejo I, López-Gutiérrez JC, Pascual Pascual SI et al (2003) Hemangiomas y malformaciones vasculares cutáneas y patología asociada. Un nuevo síndrome neurocutáneo. An Pediatr 58:339-349